Clinical Trial Update: Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update evaluates autologous dendritic cell vaccination in melanoma patients scheduled for regional lymph node dissection. The study includes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic Cell Vaccine (autologous)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma Stage III or IV | Phase 1, Phase 2 | Status: COMPLETED